NCT06753786View on ClinicalTrials.gov

Timing of Venous Thromboembolism Prophylaxis in Patients with Hypertensive Intracerebral Hemorrhage

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 21, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Venous ThromboembolismPulmonary EmbolismIntracerebral HemorrhageDeep Vein Thrombosis
Interventions
DRUG

Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting within the first 2 days but not earlier than 12 hours after a hospital admission.

Prophylactic dosage and administration of unfractionated heparin or low molecular weight heparin according to their official prescribing information.

DRUG

Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting on the 3rd day after a hospital admission.

Prophylactic dosage and administration of unfractionated heparin or low molecular weight heparin according to their official prescribing information.

Trial Locations (1)

115516

RECRUITING

Moscow City Clinical Hospital named after V.M. Buyanov, Moscow

All Listed Sponsors
lead

Pirogov Russian National Research Medical University

OTHER